Free Trial

Straumann (OTCMKTS:SAUHF) Shares Up 10.4% - Here's Why

Straumann logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares rose 10.4% intraday to $115.85 (previous close $104.95) on unusually light trading of about 742 shares, roughly a 73% drop from the average daily volume; the price is above the 50‑day MA ($111.15) and near the 200‑day MA ($115.21).
  • Straumann is a Swiss developer and manufacturer of dental implant systems and related prosthetics, biomaterials, digital dentistry technologies and practice/laboratory services, marketing itself as an end‑to‑end solutions provider for clinicians and labs.
  • MarketBeat previews the top five stocks to own by May 1st.

Straumann Holding AG (OTCMKTS:SAUHF - Get Free Report)'s share price was up 10.4% during mid-day trading on Tuesday . The company traded as high as $115.85 and last traded at $115.85. Approximately 742 shares were traded during trading, a decline of 73% from the average daily volume of 2,792 shares. The stock had previously closed at $104.9474.

Straumann Trading Up 10.4%

The stock's fifty day moving average price is $111.15 and its 200-day moving average price is $115.21.

About Straumann

(Get Free Report)

Straumann Group OTCMKTS: SAUHF is a Swiss-based developer and manufacturer of products and solutions for restorative and regenerative dentistry. The company is best known for its dental implant systems and related prosthetic components, and it has expanded its portfolio to include biomaterials, digital dentistry technologies, and practice- and laboratory-oriented services. Straumann positions itself as a provider of end-to-end solutions for clinicians, dental laboratories and dental practices aiming to restore oral function and aesthetics.

The Straumann product range covers titanium and ceramic implants, abutments, fixed and removable prosthetic solutions, bone grafting and regenerative materials, surgical instruments and guided-surgery systems.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Straumann Right Now?

Before you consider Straumann, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Straumann wasn't on the list.

While Straumann currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines